SRZNW
Surrozen, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B
Company Profile
CEO
Craig C. Parker
IPO Date
2021-08-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Surrozen, Inc.
CEO
Craig C. Parker
IPO Date
2021-08-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 25,000 |
| $0.38 |
| 22 May 2023 | Berkenblit Anna | director | A-Award | Acquired | 20,000 | $0.56 |
| 19 May 2023 | BJERKHOLT ERIC | director | A-Award | Acquired | 20,000 | $0.56 |
| 19 May 2023 | WOODHOUSE DAVID J | director | A-Award | Acquired | 20,000 | $0.56 |
| 19 May 2023 | Lin Shao-Lee | director | A-Award | Acquired | 20,000 | $0.56 |
| 5 Apr 2023 | BJERKHOLT ERIC | director | Disposed | 40,000 | $0.58 |
| 2 Mar 2023 | Parker Craig C | director, officer: Chief Executive Officer | A-Award | Acquired | 405,000 | $1.13 |
| 19 Dec 2022 | Parker Craig C | director: Chief Executive Officer | A-Award | Acquired | 9,578 | $0.41 |
| 15 Dec 2022 | BLUTT MITCHELL J MD | director | S-Sale | Disposed | 144,666 | $0.00 |